Plasmid DNA sits at the core of every cell and gene therapy, yet today’s supply chain remains slow, constrained, and reliant on legacy approaches that limit progress. The field is now reaching a point ...

TORONTO--(BUSINESS WIRE)--Novel Bio, a leader in next-generation biomanufacturing technologies for plasmid DNA for use in genetic medicines, announced today that they have formed a partnership with ...

Genetic engineering, also known as genetic modification, is a set of technologies used to change the genetic makeup of cells, including the transfer of genes within and across species boundaries to ...

DNA vaccines, wherein a new antigen is inserted into a validated vector, have tremendous potential for deployment in pandemic applications as they can be rapidly produced in a validated, ...

Bionova Scientific, an Asahi Kasei CDMO, formed a manufacturing alliance with Syenex, a genetic medicines platform company, designed to expand global access to DNA plasmids for next-generation gene ...